Recognising Effective Materials By Randomising & Assessing New Donorsite Treatments

Recognising Effective Materials By Randomising & Assessing New Donorsite Treatments - Rembrandt trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33029

Enrollment

250

Registered

2009-11-19

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

donor sites of split skin grafts

Interventions

Five different wound dressing materials will be compared, namely an alginate, a film, a hydrocolloid, a paraffin gauze, and a silicone dressing.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults Condition requiring split skin grafting Donor site of at least 10 cm2 Written informed consent.

Exclusion criteria

Exclusion criteria: Patients physically or mentally not able to give informed consent Patients with an impaired wound healing, e.g. undergoing chemotherapy.

Design outcomes

Primary

Measure	Time frame
Primary objective is to promote wound healing.	—

Secondary

Measure	Time frame
Secondary objectives are pain, comfort, infection rate, and costs.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)